Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Tam

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Development (Cambridge, England)|November 25, 2010
An interview with Patrick Tam by Kathryn SeniorPatrick Tam
F1000Research|March 10, 2020
Diversity of left-right symmetry breaking strategy in animalsHiroshi Hamada, Patrick Tam
International Journal of Molecular Sciences|October 14, 2022
Meta-Analysis Identifies <i>BDNF</i> and Novel Common Genes Differently Altered in Cross-Species Models of Rett SyndromeFlorencia Haase, Rachna Singh, Brian Gloss, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|June 13, 2015
Infliximab in the treatment of refractory ocular inflammatory diseasesKa Wai Kam, Lai Shan Tam, Mang Kwan Patrick Tam, et al.
Critical Care (London, England)|May 1, 2015
Integration of metabolic and inflammatory mediator profiles as a potential prognostic approach for septic shock in the intensive care unitBeata Mickiewicz, Patrick Tam, Craig N Jenne, et al.
British Journal of Pharmacology|November 6, 2012
Characterization of AQX-1125, a small-molecule SHIP1 activator: Part 2. Efficacy studies in allergic and pulmonary inflammation models in vivoGrant R Stenton, Lloyd F Mackenzie, Patrick Tam, et al.
British Journal of Pharmacology|November 6, 2012
Characterization of AQX-1125, a small-molecule SHIP1 activator: Part 1. Effects on inflammatory cell activation and chemotaxis in vitro and pharmacokinetic characterization in vivoGrant R Stenton, Lloyd F Mackenzie, Patrick Tam, et al.
American Journal of Medical Genetics. Part A|July 13, 2006
Deletion at 14q22-23 indicates a contiguous gene syndrome comprising anophthalmia, pituitary hypoplasia, and ear anomaliesLeisha D Nolen, David Amor, Ashley Haywood, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
Refate identifies chemical compounds to target trans-regulatory networks for cellular conversionDi Xiao, Sonu Sahadevan, Melissa M Mangala, et al.
European Journal of Clinical Pharmacology|March 6, 2008
Efficacy and safety of disodium ascorbyl phytostanol phosphates in men with moderate dyslipidemiaMaud N Vissers, Mieke D Trip, P Haydn Pritchard, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Development (Cambridge, England)|November 25, 2010
An interview with Patrick Tam by Kathryn SeniorPatrick Tam
F1000Research|March 10, 2020
Diversity of left-right symmetry breaking strategy in animalsHiroshi Hamada, Patrick Tam
International Journal of Molecular Sciences|October 14, 2022
Meta-Analysis Identifies <i>BDNF</i> and Novel Common Genes Differently Altered in Cross-Species Models of Rett SyndromeFlorencia Haase, Rachna Singh, Brian Gloss, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|June 13, 2015
Infliximab in the treatment of refractory ocular inflammatory diseasesKa Wai Kam, Lai Shan Tam, Mang Kwan Patrick Tam, et al.
Critical Care (London, England)|May 1, 2015
Integration of metabolic and inflammatory mediator profiles as a potential prognostic approach for septic shock in the intensive care unitBeata Mickiewicz, Patrick Tam, Craig N Jenne, et al.
British Journal of Pharmacology|November 6, 2012
Characterization of AQX-1125, a small-molecule SHIP1 activator: Part 2. Efficacy studies in allergic and pulmonary inflammation models in vivoGrant R Stenton, Lloyd F Mackenzie, Patrick Tam, et al.
British Journal of Pharmacology|November 6, 2012
Characterization of AQX-1125, a small-molecule SHIP1 activator: Part 1. Effects on inflammatory cell activation and chemotaxis in vitro and pharmacokinetic characterization in vivoGrant R Stenton, Lloyd F Mackenzie, Patrick Tam, et al.
American Journal of Medical Genetics. Part A|July 13, 2006
Deletion at 14q22-23 indicates a contiguous gene syndrome comprising anophthalmia, pituitary hypoplasia, and ear anomaliesLeisha D Nolen, David Amor, Ashley Haywood, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
Refate identifies chemical compounds to target trans-regulatory networks for cellular conversionDi Xiao, Sonu Sahadevan, Melissa M Mangala, et al.
European Journal of Clinical Pharmacology|March 6, 2008
Efficacy and safety of disodium ascorbyl phytostanol phosphates in men with moderate dyslipidemiaMaud N Vissers, Mieke D Trip, P Haydn Pritchard, et al.
Pageof 2